Nika Pharmaceuticals Inc(NIKA)
$0.350.00 (0.00%)
NIKA
Nika Pharmaceuticals Inc financials statements
$0.35
At close:0.00 (0.00%)
Nika Pharmaceuticals Inc (NIKA) Income Statement
5 Followers
Nika Pharmaceuticals Inc Income Statement
Last quarter (Q3 2026), Nika Pharmaceuticals Inc's total revenue was $0.00. In Q3, Nika Pharmaceuticals Inc's net income was $-13.02K. See Nika Pharmaceuticals Inc’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 76.40K | $ 95.79K | $ 64.83K | $ 3.18M | $ 14.71K | |
| Depreciation and Amortization | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| $ -76.40K | $ -95.79K | $ -64.83K | $ -3.18M | $ -14.71K | |
| $ -76.40K | $ -95.79K | $ -64.83K | $ -3.18M | $ -14.71K | |
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ -76.40K | $ -95.79K | $ -64.83K | $ -3.18M | $ -14.71K | |
| $ -76.40K | $ -95.79K | $ -64.83K | $ -3.18M | $ -14.71K | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Diluted EPS | $ -0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Weighted Average Shares Outstanding | 1.05B | 1.02B | 876.09M | 876.09M | 876.09M |
| Weighted Average Shares Outstanding (Diluted) | 1.05B | 1.02B | 876.09M | 876.09M | 876.09M |
Currency in USD

